NBS

Neostem, Inc. News Headlines

$6.1
*  
0.03
0.49%
Get NBS Alerts
*Delayed - data as of Jul. 29, 2014  -  Find a broker to begin trading NBS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cellular Therapy: Representing The Paradigm Shift In Healthcare
12/31/2013 8:50:00 AM - Seeking Alpha

Who Will Win The Stem Cell Race?
12/24/2013 6:47:00 AM - Seeking Alpha

Neostem Stands To Benefit From Stem-Cell Deals
12/23/2013 9:20:00 AM - Seeking Alpha

NeoStem: Continued Progress And 2014 Catalysts
12/19/2013 2:33:00 PM - Seeking Alpha

Why Is Complete Enrollment Important To NeoStem Investors?
12/17/2013 5:27:00 AM - Seeking Alpha

Sector Update: Healthcare Shares Flat to Lower; Lexicon Drops 13% on Phase 2 Study of IBS Treatment
12/3/2013 9:27:53 AM - MT Newswires

Sector Update: Healthcare
12/3/2013 9:24:34 AM - MT Newswires

NeoStem: Major Developments You Might Have Missed
10/30/2013 8:00:00 AM - Seeking Alpha

NeoStem: Catalysts Upcoming, Financing In Rear View Mirror
10/28/2013 2:43:00 PM - Seeking Alpha

Celgene And NeoStem: 2 Biopharmaceutical Companies Poised For Growth
10/21/2013 12:33:00 PM - Seeking Alpha

Stem Cell Therapy: Coming Into Maturity And Becoming Medical Reality
10/18/2013 10:16:00 AM - Seeking Alpha

This Short-Term Pain Might Be Best For Long-Term Gain
10/15/2013 3:01:00 AM - Seeking Alpha

NeoStem, Inc. Robin L. Smith, M.D., MBA - Chairman and CEO Signature Series
10/14/2013 6:05:23 PM - Nasdaq CEO Signature Series

Companies Race To Develop The Next Novel Blockbuster Diabetes Drug - Part 2
10/6/2013 5:12:00 AM - Seeking Alpha

NeoStem: An Investment In 4 Different Divisions
9/30/2013 8:23:00 AM - Seeking Alpha

Neostem: A Multi-Faceted Stem Cell Sector Play
9/24/2013 4:57:00 PM - Seeking Alpha

NeoStem: Understanding Research And Its Implications To Clinical Trials
9/18/2013 1:25:00 PM - Seeking Alpha

NeoStem Continues To Soar Behind A Slew Of Key Developments
9/16/2013 2:17:00 PM - Seeking Alpha

Competition Landscape Looks Much Brighter For Sunshine Heart After Stem-Cell Therapy Failure
9/16/2013 10:30:00 AM - Seeking Alpha

Healthcare Stocks Back Near Even For Session; Neostem Hits New 52-Week High After Banking NIH Grant
9/12/2013 2:37:46 PM - MT Newswires

Sector Update: Healthcare
9/12/2013 2:32:03 PM - MT Newswires

Novartis And NeoStem: Developing Therapies To Extend The Quality Of Life For Heart Disease Patients
9/12/2013 3:06:00 AM - Seeking Alpha

Why Neuralstem Represents An Enormous Opportunity For Investors
9/9/2013 9:59:00 AM - Seeking Alpha

NeoStem And Neuralstem: 2 Early Regenerative Medicine Winners
9/8/2013 2:40:00 PM - Seeking Alpha

These 3 Countries Could Be Headed For A Meltdown
8/29/2013 3:15:19 AM - StreetAuthority